MEI Pharma extends CFO Brian Drazba's retirement to June 30, 2022
Lite Strategy, Inc.
CFO Brian Drazba's employment extended to June 30, 2022, under amended retirement agreement.
Mr. Drazba eligible for $414,140 severance (12 months' base salary) if he leaves other than for cause.
Outstanding stock options will vest as if employment continued through first anniversary of retirement date; exercise period extended to one year post-retirement.
Accelerated vesting and exercise benefits contingent on signing release and complying with restrictive covenants.
On December 21, 2021, Mr. Drazba and the Company mutually agreed to extend the term of Mr. Drazba’s employment to June 30, 2022 (or an earlier date determined by either party), pursuant to a letter agreement dated December 21, 2021 (the “Letter Agreement”).
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Brian G. Drazba departed as Chief Financial Officer at Lite Strategy, Inc..
Action
retirement
Role
Chief Financial Officer
Exact text from the filing
On December 21, 2021, Mr. Drazba and the Company mutually agreed to extend the term of Mr. Drazba’s employment to June 30, 2022 (or an earlier date determined by either party), pursuant to a letter agreement dated December 21, 2021 (the “Letter Agreement”).
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.